Emtricitabine Recruiting Phase 4 Trials for Neurocognitive Dysfunction / Human Immunodeficiency Virus (HIV) Infections Treatment

IndicationsStatusPurposePhase
RecruitingTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03163277Using Less Neurotoxic Drugs in Patients With HAND (MARAND-X)
NCT02656511Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
NCT03685500A Clinical Trial to Evaluate the Reversibility of Abacavir/Lamivudine/Dolutegravir CNS-Related Neurotoxicity After Switching to Tenofovir/Alafenamide/Emtricitabine/Darunavir/Cobicistat (TAF/FTC/DRV/c)
NCT03675815Body Composition Sub-study of the D2EFT Trial